Cutaneous leukocytoclastic vasculitis associated with letrozole.
Disciplines
Article
English
ID: <
10670/1.1cuedi>
Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.